Back

Acute and chronic changes in LV performance in patients with primary severe mitral regurgitation undergoing percutaneous mitral valve repair

9 December 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Advances in heart valve imaging Valvular Heart Disease EACVI Premium Access EuroEcho 2021

About the speaker

Photo
Professor Elena Galli

University Hospital of Strasbourg, Strasbourg (France)

5 More presentations in this session

Presentation thumbnail
The MIDA quantitative international registry: prognostic implications of moderately elevated pulmonary artery pressure
Doctor B. Essayagh (Cannes, FR)
Abstract Slides Video
Presentation thumbnail
Comparison of mitral regurgitant volume assessment between proximal flow convergence and volumetric methods in patients with significant primary mitral regurgitation
Doctor A. Altes (Lille, FR)
Abstract Slides Video
Presentation thumbnail
Magnetic resonance derived regurgitant fraction, 3D vena contracta area, and B-natriuretic peptide: the most accurate prognostic markers in patients with chronic asymptomatic aortic regurgitation
Doctor R. Kockova (Hradec Kralove, CZ)
Abstract Slides Video
Presentation thumbnail
Rate of transesophageal echocardiography related complications during 1229 TEE-guided structural heart disease procedures
Doctor E. Kronzer (Rochester, US)
Abstract Slides Video
Presentation thumbnail
Increasing transvalvular flow with passive leg rise as an add-on to dobutamine in patients with paradoxical low-flow, low-gradient aortic stenosis
Doctor E. Buffle (Paris, FR)
Abstract Slides Video

Access the full session

Session thumbnail
Advances in heart valve imaging

The Event

Event poster

EuroEcho 2021

9 December - 11 December 2021
You may be interested in
thumbnail
Congress Presentation
Valvular heart disease
thumbnail
Congress Presentation
When to use cardiac magnetic resonance in aortic stenosis
thumbnail
Congress Presentation
Assessment of aortic BVD: step-by-step approach

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources